Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply
Go back to Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply| (NASDAQ: BNTX) | Delayed: 89.67 -1.62 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.29 | 52 Week High | $ | |||
| Open | $90.75 | 52 Week Low | $ | |||
| Day High | $92.73 | P/E | N/A | |||
| Day Low | $89.03 | EPS | $ | |||
| Volume | 1,164,458 | |||||



